Adsorbed purified liquid diphtheria-tetanus toxoid.
Trade name
ATD-toxoid
Dosage form
Suspension for intramuscular injection
Shelf life
3 years
Manufacturer
NPO Microgen, 177, Bratskaya str., Perm, Perm Territory, 614089 Russia; and 105 Novorossiyskaya str., Ufa, Republic of Bashkortostan, 450014 Russia
Presentation
Suspension for intramuscular injection in 0.5 ml ampoules (one vaccination dose) or 1 ml ampoules (2 vaccination doses) 10 ampoules in the box with a package insert and an ampoule cutter, or 5 ampoules in PVC dose trays, 2 dose trays in each package with a package insert and an ampoule cutter. If the ampoule has a score line, a ring or a dot, an ampoule cutter is not inserted.
Ingredients
ADT-toxoid consists of a mixture of purified diphtheria and tetanus toxoid adsorbed on aluminum hydroxide.
1 dose (0.5 ml) contains:
- 30 flocculating units (Lf) of diphtheria toxoid and
- 10 binding units (BU) of tetanus toxoid
Excipients: not more than 0.55 mg of aluminum hydroxide equivalent to aluminum, 42.5 to 57.5 µg of thiomersal and not more than 50 µg of formaldehyde.
Indications
Prevention of diphtheria and tetanus in children